Russia’s Pharmstandard Allocates $12 Million for its Kursk Plant Modernization

Russia’s largest pharmaceutical manufacturer, Pharmstandard, has pledged to invest Rb330 million ($12 million) into the modernisation of its facility in Kursk, a city 530 kilometres south-west of Moscow.

MORE ON THIS TOPIC